1. Home
  2. NRP vs COLL Comparison

NRP vs COLL Comparison

Compare NRP & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Natural Resource Partners LP Limited Partnership

NRP

Natural Resource Partners LP Limited Partnership

HOLD

Current Price

$97.60

Market Cap

1.3B

Sector

Energy

ML Signal

HOLD

Logo Collegium Pharmaceutical Inc.

COLL

Collegium Pharmaceutical Inc.

HOLD

Current Price

$35.63

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NRP
COLL
Founded
2002
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Coal Mining
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.1B
IPO Year
2002
2015

Fundamental Metrics

Financial Performance
Metric
NRP
COLL
Price
$97.60
$35.63
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$51.40
AVG Volume (30 Days)
36.0K
428.1K
Earning Date
05-06-2026
05-07-2026
Dividend Yield
2.56%
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.40
Revenue
$216,119,000.00
$780,567,000.00
Revenue This Year
N/A
$8.01
Revenue Next Year
N/A
N/A
P/E Ratio
$11.28
$88.98
Revenue Growth
54.66
23.62
52 Week Low
$95.51
$29.19
52 Week High
$128.60
$50.79

Technical Indicators

Market Signals
Indicator
NRP
COLL
Relative Strength Index (RSI) 41.89 50.02
Support Level $97.39 $33.91
Resistance Level $101.78 $35.76
Average True Range (ATR) 2.26 1.41
MACD 0.20 -0.14
Stochastic Oscillator 33.96 31.15

Price Performance

Historical Comparison
NRP
COLL

About NRP Natural Resource Partners LP Limited Partnership

Natural Resources Partners LP is a diversified natural resource company. It is engaged in the business of owning, managing and leasing a diversified portfolio of mineral properties in the United States, including interests in coal, trona and soda ash, crude oil and natural gas, construction aggregates, frac sand, and other natural resources. The company leases coal reserves to experience mine operators under long-term leases that grant the operator the right to mine its coal reserves in exchange for royalty payments. The company operates in two reportable segments namely: Mineral Rights and Soda Ash. The majority of the revenue is generated from the Mineral Rights segment. Geographically, the company's business activity of the group functions through the United States.

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The company has developed, licensed, and acquired a portfolio of meaningfully differentiated products for the treatment of attention deficit hyperactivity disorder (ADHD) and moderate to severe pain. It commercializes its products in the United States, including Jornay PM, Belbuca, Xtampza ER, Nucynta ER, Nucynta IR (collectively, the Nucynta Products), and Symproic. The company's product portfolio includes Jornay PM, Belbuca, Xtampza ER, Nucynta IR, Nucynta ER, and Symproic.

Share on Social Networks: